Covered recipient · General Payments record
CHARLES OKOROM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022–2024
$598.97
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.16 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $135.64 | 3 |
| Janssen Pharmaceuticals, Inc | $75.07 | 2 |
| ABBVIE INC. | $68.91 | 3 |
| Neurocrine BioSciences, Inc. | $51.94 | 2 |
| Corium, Inc. | $51.24 | 3 |
| Lundbeck LLC | $17.67 | 1 |
| Tempus AI, Inc | $15.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.99 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107759808 | CMS |
| ABBVIE INC. | $28.62 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107759810 | CMS |
| ABBVIE INC. | $19.30 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107759812 | CMS |
| Corium, LLC | $18.84 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100101684 | CMS |
| Corium, LLC | $24.06 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100085666 | CMS |
| Corium, LLC | $8.34 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100126016 | CMS |
| Janssen Pharmaceuticals, Inc | $30.86 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078047054 | CMS |
| Janssen Pharmaceuticals, Inc | $44.21 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078047062 | CMS |
| Lundbeck LLC | $17.67 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146070050 | CMS |
| Neurocrine Biosciences, Inc. | $29.03 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150942109 | CMS |
| Neurocrine Biosciences, Inc. | $22.91 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150964385 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.97 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147874975 | CMS |
| Supernus Pharmaceuticals, Inc. | $118.62 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147874977 | CMS |
| Supernus Pharmaceuticals, Inc. | $3.05 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147874973 | CMS |
| Tempus AI, Inc | $15.69 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150243398 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.